(Total Views: 455)
Posted On: 09/04/2020 3:22:51 PM
Post# of 11803
Re: Pathnder11 #11130
@pathfinder11
My guess is, receiving the antigen test EUA has always been a moving target, especially for a micro cap company. The FDA has altered the requirements for an application numerous times. KB has stated he wanted his GenViro application to be all inclusive. It probably helps to have another similar type test be approved. DECN could never have been the first. Who knows KB might have held back until Abbott got it's OK. Also, this test was taunted originally as an at home test. How does that work in a world that counts tests results daily?
There has always been another path for GenViro. America has less than 5% of the worlds potential infected people. The FDA is important but, even much more important is GenViro's accuracy rate. I hear India has 1.4 billion people.
My guess is, receiving the antigen test EUA has always been a moving target, especially for a micro cap company. The FDA has altered the requirements for an application numerous times. KB has stated he wanted his GenViro application to be all inclusive. It probably helps to have another similar type test be approved. DECN could never have been the first. Who knows KB might have held back until Abbott got it's OK. Also, this test was taunted originally as an at home test. How does that work in a world that counts tests results daily?
There has always been another path for GenViro. America has less than 5% of the worlds potential infected people. The FDA is important but, even much more important is GenViro's accuracy rate. I hear India has 1.4 billion people.
(1)
(0)
